Kotaki, T.; Nagai, Y.; Yamanaka, A.; Konishi, E.; Kameoka, M.
Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection. Vaccines 2022, 10, 1411.
https://doi.org/10.3390/vaccines10091411
AMA Style
Kotaki T, Nagai Y, Yamanaka A, Konishi E, Kameoka M.
Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection. Vaccines. 2022; 10(9):1411.
https://doi.org/10.3390/vaccines10091411
Chicago/Turabian Style
Kotaki, Tomohiro, Yurie Nagai, Atsushi Yamanaka, Eiji Konishi, and Masanori Kameoka.
2022. "Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection" Vaccines 10, no. 9: 1411.
https://doi.org/10.3390/vaccines10091411
APA Style
Kotaki, T., Nagai, Y., Yamanaka, A., Konishi, E., & Kameoka, M.
(2022). Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection. Vaccines, 10(9), 1411.
https://doi.org/10.3390/vaccines10091411